ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 572,46
-0,79%
Dow Jones
40 211,72
0,53%
DAX
18 506,38
-0,50%
Brent Oil
83,325
-1,20%
Bitcoin
63 430,12
-2,19%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Portola Pharmaceuticals Inc (PTLA)

  7. Portola Pharmaceuticals Inc (PTLA) Actualités

PTLA

Portola Pharmaceuticals (PTLA)

Portola Pharmaceuticals Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:PTLA
DateHeureSourceTitreSymboleSociété
09/11/201712h09Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PTLAPortola Pharmaceuticals Inc
08/11/201723h29Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:PTLAPortola Pharmaceuticals Inc
07/11/201714h00GlobeNewswire Inc.Portola Pharmaceuticals Announces New APEX Study Sub-Analyses Data on Betrixaban to be Presented at the America Heart Associa...NASDAQ:PTLAPortola Pharmaceuticals Inc
06/11/201722h36Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PTLAPortola Pharmaceuticals Inc
06/11/201722h01GlobeNewswire Inc.Portola Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Corporate UpdateNASDAQ:PTLAPortola Pharmaceuticals Inc
06/11/201714h00GlobeNewswire Inc.Portola Pharmaceuticals Appoints Industry Veteran John H. Lawrence, M.D., as Senior Vice President of Product Development and...NASDAQ:PTLAPortola Pharmaceuticals Inc
03/11/201713h00GlobeNewswire Inc.Portola Pharmaceuticals to Present at the Credit Suisse 26th Annual Healthcare ConferenceNASDAQ:PTLAPortola Pharmaceuticals Inc
30/10/201713h00GlobeNewswire Inc.Portola Pharmaceuticals to Announce Third Quarter 2017 Financial Results and Host Conference Call on Monday, November 6NASDAQ:PTLAPortola Pharmaceuticals Inc
11/10/201722h05GlobeNewswire Inc.Portola Pharmaceuticals Supports 2017 World Thrombosis Day Campaign to Raise Awareness about the Persistent Risk of Blood Clo...NASDAQ:PTLAPortola Pharmaceuticals Inc
03/10/201722h05GlobeNewswire Inc.Portola Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:PTLAPortola Pharmaceuticals Inc
30/09/201700h26Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PTLAPortola Pharmaceuticals Inc
13/09/201722h26Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:PTLAPortola Pharmaceuticals Inc
13/09/201704h39GlobeNewswire Inc.Portola Announces Pricing of Public Offering of Common StockNASDAQ:PTLAPortola Pharmaceuticals Inc
11/09/201722h01GlobeNewswire Inc.Portola Pharmaceuticals Announces Proposed Offering of Common StockNASDAQ:PTLAPortola Pharmaceuticals Inc
06/09/201714h00GlobeNewswire Inc.Portola Pharmaceuticals to Present at the 2017 Morgan Stanley Global Healthcare ConferenceNASDAQ:PTLAPortola Pharmaceuticals Inc
05/09/201714h00GlobeNewswire Inc.Reminder: Portola Pharmaceuticals to Host Webcast and Conference Call Today, Tuesday, Sept. 5 to Provide Further Details on B...NASDAQ:PTLAPortola Pharmaceuticals Inc
02/09/201700h34GlobeNewswire Inc.Portola Pharmaceuticals to Host Webcast and Conference Call Tuesday, Sept. 5 to Provide Further Details on Bevyxxa® (betrixa...NASDAQ:PTLAPortola Pharmaceuticals Inc
21/08/201714h00GlobeNewswire Inc.Portola Pharmaceuticals Announces Upcoming Data Presentations on Betrixaban and Andexanet Alfa at the European Society of Car...NASDAQ:PTLAPortola Pharmaceuticals Inc
15/08/201714h00GlobeNewswire Inc.Portola Pharmaceuticals Announces AndexXa® (Andexanet Alfa) Biologics License Application Resubmission Accepted for Review b...NASDAQ:PTLAPortola Pharmaceuticals Inc
09/08/201722h25GlobeNewswire Inc.Portola Pharmaceuticals Reports Second Quarter 2017 Financial Results and Provides Corporate UpdateNASDAQ:PTLAPortola Pharmaceuticals Inc
03/08/201722h13GlobeNewswire Inc.Portola Pharmaceuticals Announces Resubmission of Biologics License Application for AndexXa® (Andexanet Alfa)NASDAQ:PTLAPortola Pharmaceuticals Inc
02/08/201714h00GlobeNewswire Inc.Portola Pharmaceuticals to Announce Second Quarter 2017 Financial Results and Host Conference Call on Wednesday, August 9NASDAQ:PTLAPortola Pharmaceuticals Inc
17/07/201722h05Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:PTLAPortola Pharmaceuticals Inc
06/07/201714h00GlobeNewswire Inc.Portola Pharmaceuticals Announces Upcoming Data Presentations on Betrixaban and Andexanet Alfa at the International Society o...NASDAQ:PTLAPortola Pharmaceuticals Inc
23/06/201719h04GlobeNewswire Inc.U.S. FDA Approves Bevyxxa® (betrixaban) First and Only Anticoagulant for Hospital and Extended Duration Prevention of Venou...NASDAQ:PTLAPortola Pharmaceuticals Inc
15/06/201714h30GlobeNewswire Inc.Portola Pharmaceuticals Presents Interim Phase 2a Safety and Efficacy Data for Cerdulatinib at the International Congress of ...NASDAQ:PTLAPortola Pharmaceuticals Inc
06/06/201723h08Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:PTLAPortola Pharmaceuticals Inc
18/05/201714h00GlobeNewswire Inc.Portola Pharmaceuticals Announces Phase 2a Safety and Efficacy Cerdulatinib Data to be Presented at the European Hematology A...NASDAQ:PTLAPortola Pharmaceuticals Inc
09/05/201714h00GlobeNewswire Inc.Portola Pharmaceuticals Announces Cerdulatinib Data to be Presented at the International Conference on Malignant Lymphoma (IC...NASDAQ:PTLAPortola Pharmaceuticals Inc
08/05/201722h36GlobeNewswire Inc.Portola Pharmaceuticals Reports First Quarter 2017 Financial Results and Provides Corporate UpdateNASDAQ:PTLAPortola Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:PTLA

Dernières Valeurs Consultées

NASDAQ
AAPL
Apple
EU
CAP
Capgemini
EU
HO
Thales
NASDAQ
GOOGL
Alphabet
COIN
BTCUSD
Bitcoin
NYSE
DIS
Walt Disney
EU
RNO
Renault
SPI
SP500
S&P 500
EU
GLE
Societe Generale
FTSE
UKX
FTSE 100
EU
AF
Air FranceKLM
EU
BEL20
Bel 20
EU
BNP
BNP Paribas
EU
VK
Vallourec
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés